Cofactor Binding Triggers a Molecular Switch To Allosterically Activate Human UDP-α-d-glucose 6-Dehydrogenase

Biochemistry
2012.0

Abstract

Human UDP-α-D-glucose dehydrogenase (hUGDH) catalyzes the NAD(+)-dependent oxidation of UDP-α-D-glucose (UDG) to produce UDP-α-D-glucuronic acid. The oligomeric structure of hUGDH is dynamic and can form two distinct hexameric complexes in solution. The active form of hUGDH consists of dimers that undergo a concentration-dependent association to form a hexamer with 32 symmetry. In the presence of the allosteric feedback inhibitor UDP-α-D-xylose (UDX), hUGDH changes shape to form an inactive, horseshoe-shaped complex. Previous studies have identified the UDX-induced allosteric mechanism that changes the hexameric structure to inhibit the enzyme. Here, we investigate the role of the 32 symmetry hexamer in the catalytic cycle. We engineered a stable hUGDH dimer by introducing a charge-switch substitution (K94E) in the hexamer-building interface (hUGDH(K94E)). The k(cat) of hUGDH(K94E) is ~160-fold lower than that of the wild-type enzyme, suggesting that the hexamer is the catalytically relevant state. We also show that cofactor binding triggers the formation of the 32 symmetry hexamer, but UDG is needed for the stability of the complex. The hUGDH(K94E) crystal structure at 2.08 Å resolution identifies loop(88-110) as the cofactor-responsive allosteric switch that drives hexamer formation; loop(88-110) directly links cofactor binding to the stability of the hexamer-building interface. In the interface, loop(88-110) packs against the Thr131-loop/α6 helix, the allosteric switch that responds to the feedback inhibitor UDX. We also identify a structural element (the S-loop) that explains the indirect stabilization of the hexamer by substrate and supports a sequential, ordered binding of the substrate and cofactor. These observations support a model in which (i) UDG binds to the dimer and stabilizes the S-loop to promote cofactor binding and (ii) cofactor binding orders loop(88-110) to induce formation of the catalytically active hexamer.

Knowledge Graph

Similar Paper

Cofactor Binding Triggers a Molecular Switch To Allosterically Activate Human UDP-α-<scp>d</scp>-glucose 6-Dehydrogenase
Biochemistry 2012.0
Active site mutants of the “non-hydrolyzing” UDP-N-acetylglucosamine 2-epimerase from Escherichia coli
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2004.0
Probing UDP-galactopyranose mutase binding pocket: A dramatic effect on substitution of the 6-position of UDP-galactofuranose
Bioorganic &amp; Medicinal Chemistry Letters 2009.0
A Two-Base Mechanism for <i>Escherichia coli</i> ADP-<scp>l</scp>-<i>glycero</i>-<scp>d</scp>-<i>manno</i>-Heptose 6-Epimerase
Biochemistry 2007.0
Genome-wide analysis of the UDP-glucose dehydrogenase gene family in Arabidopsis, a key enzyme for matrix polysaccharides in cell walls
Journal of Experimental Botany 2007.0
Structure−Activity Relationship of Uridine 5‘<b>-</b>Diphosphoglucose Analogues as Agonists of the Human P2Y<sub>14</sub> Receptor
Journal of Medicinal Chemistry 2007.0
Inhibition of UDP-N-Acetylglucosamine Import into Golgi Membranes by Nucleoside Monophosphates
Journal of Medicinal Chemistry 1996.0
A 2.13 Å Structure of E. coli Dihydrofolate Reductase Bound to a Novel Competitive Inhibitor Reveals a New Binding Surface Involving the M20 Loop Region
Journal of Medicinal Chemistry 2006.0
Biosynthesis of Tetrahydrofolate in Plants: Crystal Structure of 7,8-Dihydroneopterin Aldolase from Arabidopsis thaliana Reveals a Novel Adolase Class
Journal of Molecular Biology 2004.0
Human P2Y<sub>6</sub> Receptor:  Molecular Modeling Leads to the Rational Design of a Novel Agonist Based on a Unique Conformational Preference
Journal of Medicinal Chemistry 2005.0